Hodgkin and non-Hodgkin lymphomas in the post-antiretroviral therapy era according to HIV virological suppression
| dc.contributor.author | Aldámiz Echevarría, Teresa | |
| dc.contributor.author | Tejerina, Francisco | |
| dc.contributor.author | Fanciulli, Chiara | |
| dc.contributor.author | Díez, Cristina | |
| dc.contributor.author | Pérez, Leire | |
| dc.contributor.author | Bellón Cano, José María | |
| dc.contributor.author | Espinosa, Nuria | |
| dc.contributor.author | Moreno Guillén, Santiago | |
| dc.contributor.author | Arcos Rueda, María del Mar | |
| dc.contributor.author | Suárez García, Inés | |
| dc.contributor.author | Et. al. | |
| dc.date.accessioned | 2026-08-27T10:57:07Z | |
| dc.date.available | 2026-08-27T10:57:07Z | |
| dc.date.issued | 2026 | |
| dc.description.abstract | Lymphomas remain among the most frequent HIV-associated malignancies, with risk persisting despite effective virological control. This study describes the clinical, epidemiological and prognostic characteristics of lymphomas (both Hodgkin and non-Hodgkin) in people living with HIV, according to virological suppression at diagnosis and assesses lymphoma-related mortality at 1 year and overall survival at 5 years. | en |
| dc.description.filiation | UEM | spa |
| dc.description.impact | 3.2 Q2 JCR 2025 | |
| dc.description.impact | 1.060 Q1 SJR 2025 | |
| dc.description.impact | No data IDR 2024 | |
| dc.description.sponsorship | CIBER-Consorcio Centro de Investigaci on Biomédica en Red (CB21/13/00091) | es |
| dc.identifier.citation | Aldámiz‐Echevarria, T., Tejerina, F., Fanciulli, C., Diez, C., Perez, L., Bellón, J. M., Espinosa, N., Guillén, S. M., Del Mar Arcos‐Rueda, M., Montero‐Alonso, M., García‐Fraile, L., Asensi, V., López, M. F., Corona‐Mata, D., Cabello‐Úbeda, A., Manso, M. G., Iribarren, J. A., Pérez‐Martínez, L., Valls, M. R. A., … CoRIS Cohort. (2026). Hodgkin and non‐Hodgkin lymphomas in the post‐antiretroviral therapy era according to HIV virological suppression. HIV Medicine, 27(8), 1312-1332. https://doi.org/10.1111/hiv.70257 | |
| dc.identifier.doi | 10.1111/hiv.70257 | |
| dc.identifier.issn | 1464-2662 | |
| dc.identifier.issn | 1468-1293 | |
| dc.identifier.uri | https://hdl.handle.net/11268/17384 | |
| dc.language.iso | eng | |
| dc.peerreviewed | Si | |
| dc.relation.publisherversion | https://doi.org/10.1111/hiv.70257 | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | en |
| dc.rights.accessRights | open access | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject.other | Departamento clínico | |
| dc.subject.other | VIH | |
| dc.subject.other | Linfoma | |
| dc.subject.other | Virología | |
| dc.subject.sdg | Goal 3: Ensure healthy lives and promote well-being for all at all ages | |
| dc.subject.unesco | Sida | |
| dc.subject.unesco | Virología | |
| dc.subject.unesco | Medicina preventiva | |
| dc.title | Hodgkin and non-Hodgkin lymphomas in the post-antiretroviral therapy era according to HIV virological suppression | |
| dc.type | journal article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | c319367b-46e4-44b2-98ea-a3b303e36262 | |
| relation.isAuthorOfPublication.latestForDiscovery | c319367b-46e4-44b2-98ea-a3b303e36262 |
Files
Original bundle
1 - 1 of 1

